Keyphrases
Chemotherapy
100%
Cisplatin
100%
Phase II Study
100%
Newly Diagnosed
100%
Cranial Irradiation
100%
Continuous Infusion
100%
Carmustine
100%
High-grade Astrocytoma
100%
Progressive Disease
66%
Peripheral Neuropathy
33%
Contrast Enhancement
33%
Karnofsky Performance Status
33%
Leukopenia
33%
Stable Disease
33%
Partial Response
33%
Response to Chemotherapy
33%
Nausea-vomiting
33%
Survival Rate
33%
Chemotherapy Regimen
33%
Measurable Disease
33%
Neutropenic Fever
33%
Intracranial Hemorrhage
33%
Anaplastic Astrocytoma
33%
Treatment-related Mortality
33%
Hearing Impairment
33%
Continuous Intravenous Infusion
33%
Median Survival Time
33%
Glioblastoma multiforme
33%
Patient-completed
33%
Antineoplastic Drugs
33%
Platelet Transfusion
33%
Intracranial Treatment
33%
Nursing and Health Professions
Disease
100%
Cisplatin
100%
Continuous Infusion
100%
Carmustine
100%
Astrocytoma
100%
Skull Irradiation
100%
Infusion
75%
Glioblastoma
50%
Nausea
25%
Intravenous Drug Administration
25%
Brain Hemorrhage
25%
Survival Rate
25%
Median Survival Time
25%
Hearing Impairment
25%
Anticarcinogen
25%
Thromboembolism
25%
Thrombocyte Transfusion
25%
Karnofsky Performance Status
25%
Peripheral Neuropathy
25%
Leukopenia
25%
Febrile Neutropenia
25%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Chemotherapy
100%
Cisplatin
100%
Carmustine
100%
Astrocytoma
100%
Glioblastoma
50%
Anticarcinogen
25%
Peripheral Neuropathy
25%
Survival Rate
25%
Thromboembolism
25%
Nausea
25%
Chemotherapy Regimens
25%
Febrile Neutropenia
25%
Brain Hemorrhage
25%
Leukopenia
25%
Hearing Impairment
25%
Median Survival Time
25%
Neuroscience
Astrocytoma
100%
Cisplatin
100%
Carmustine
100%
Cerebral Hemorrhage
25%
Platelet
25%
Glioblastoma Multiforme
25%
Peripheral Neuropathy
25%
Chemotherapy Regimens
25%
Anticarcinogen
25%